Percutaneous penetration enhancement in transdermal drug delivery
Main Article Content
Abstract
therapy is non-invasive. The main obstacle to permeating drug molecules is the outermost layer of the skin, the stratum corneum. Consequently, research into enhancing transdermal drug delivery (TDD) by overcoming this layer, is an area
of prime interest. This review article is written to provide a coverage commentary of the recent advancements in TDD
enhancement techniques.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Liu PC, Bergstrom TK. Quantitative evaluation of aqueous isopropyl
alcohol enhancement on skin flux of terbuteline (sulfate). 2.
Permeability contributions of equilibrated drug species across human
skin in vitro. J Pharm Sci 1996;85:320-5.
Valenta C, Siman U, Kratzel M, Hadgraft J. The dermal delivery of
lignocaine: Influence of ion pairing. Int J Pharm 2000;197:77-85.
Boroujerdi M. Kinetics of ion-pair absorption. Drug Dev Ind Pharm
;13:181-91.
Takahashi K, Rytting JH. Novel approach to improve ondansetron across
snake skin as model membrane. J Pharm Pharmacol 2001;53:789-94.
Zhang JY, Fang L, Tan Z, Wu J, He ZG. Influence of ion-pairing and
chemical enhancers on the transdermal delivery of meloxicam. Drug
Dev Ind Phar 2009;35:663-70.
Neubert R. Ion pair transport across membranes. Pharm Res 1989;6:
-7.
Higuchi T. Physical chemical analysis of percutaneous absortion from
creams and oitments. J Soc Cosmet Chem 1959;11:85-97.
Megrab NA, Williams AC, Barry BW. Oestridiol permeation through
human skin and silastic membrane: Effect of propylene glycol and
supersaturation. J Control Release 1995;36:277-94.
Davis AF, Barry BW. Effect of supersaturation on membrane transport.
Hydrocortisone acetate. Int J Pharm 1991;76:1-8.
Monica LR, Stuart AJ, Marc BB. Transient drug supersaturation kinetics
of beclomethasone dipropionate in rapidly drying films. International
Journal of Pharmaceutics 2009; 371:114-9.
Leveque N, Raghavan SL, Lane ME, Hadgraf J. Use of a molecular form
technique for the penetration of supersaturated solutions of salicylic
acid across silicone membranes and human skin in vitro. Int J Pharm
;318:49-54.
Hadgraft J. Skin deep. Eur J Pharm Biopharm 2004;58:291-9.
Martin A. Physical Chemical Principles in the Pharmaceutical Sciences.
Philadelphia, Lea and Febiger: Lippincott Williams and Wilkins; 1993.
Hemstrom CA, Evans RL, Lobeck FG. Haloperidol decanoate: A depot
antipsychotic. Drug Intell Clin Pharm 1988;22:290-5.
Albert A. Chemical aspects of selective toxicity. Nature 1958;182:
-3.
Rautio J, Nevalainen T, Taipale H. Piperazinyalkyl prodrug of naproxen
improve in vitro skin permeation. Eur J Pharm Sci 2000;11:157-63.
Wang JJ, Sung KC, Huang JF, Yeh CH, Fang JY. Ester prodrugs of morphine
improve transdermal drug delivery: A mechanistic study. J Pharm
Pharmacol 2007;59:917-25.
Morris AP, Brain KR, Heard CM. Skin permeation and ex-vivo skin
metabolism of O-acyl haloperidol ester prodrugs. Int J Pharm
;367:44-50.
Thorsteinsson T, Másson M, Jarvinen T, Nevalainen T, Loftsson T.
Cycloserine fatty acid derivatives as prodrugs: synthesis, degradation
and in vitro skin permeability. Chem Pharm Bull (Tokyo) 2002;50:
-7.
Touitou E, Chow DD, Lawter JR. Chiral beta-blockers for transdermal
delivery. Int J Pharm 1994;104:19-28.
Stott PW, Williams AC, Barry BW. Transdermal delivery from eutectic
systems: Enhanced permeation of a model drug, ibuprofen. J Control
Release 1998;50:297-308.
Kang LS, Jun HW, McCall JW. Physicochemical studies of lidocaine-
menthol binary systems for enhanced membrane transport. Int J Pharm
;206:35-42.
Magnusson BM, Walters KA, Roberts MS. Veterinary drug delivery:
Potential for skin penetration enhancement. Adv Drug Deliv Rev
;50:205-27.
Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev
;56:603-18.
Idson B. Hydration and percutaneous absorption. Curr Probl Dermatol
;7:132-41.
Hadgraft J, Guy RH. Transdermal drug delivery: Revisved and expanded.
nd ed. New York: Marcel Dekker; 2006.
van Hal DA, Jeremiasse E, Junginger HE, Spies F, Bouwstra JA. Structure
of fully hydrated human stratum Cornrum: A freeze fracture electron
microscopy study. J Invest Dermatol 1996;106:89-95.
Kligman AM. Topical pharmacology and toxicology of dimethysulfoxide.
JAMA 1965;193:796-804.
Southwell D, Barry BW. Penetration enhancers for human skin: Mode
of action of 2-pyrrolidone and dimethylformamide on partition and
diffusion of model compounds water, n-alcohols and caffeine. J Invest
Dermatol 1983;80:507-15.
Wiechers JW, Drenth BF, Jonkman JH, de Zeeuw RA. Percutaneous
absorption and elimination of the penetration enhancer azone in
humans. Pharm Res 1987;4:519-23.
Pilgram GS, van der Meulen J, Gooris GS, Koerten HK, Bouwstra JA. The
influence of two azones and sebaceous lipids on the lateral organisation
of lipids isolated from human stratum corneum. Biochimica et
Biophysica Acta 2001;1511:244-54.
Leonard MF, Kumar A, Murray DL, Beaman DC. Inhibitory effect of
azone® (1-dodecylazacycloheptan-2-one) on herpes simplex viruses.
Chemotherapy 1987;33:151-6.
Aungst BJ, Rogers NJ, Shefter E. Enhancement of naloxone penetration
through human skin in vitro using fatty acids, fatty alcohols, surfactants,
sulfoxides and amines. Int J Pharm 1986;33:225.
Ongpipattanakul B, Burnette RR, Potts RO, Francoeur ML. Evidence
that oleic acid exist in a separate phase within stratum corneum lipids.
Pharm Res 1991;7:350-4.
Smith EW, Maibach HI. Percutaneous penetration enhancers. Boca
Raton, FL: CRC/Taylor and Francis; 2005.
Thong HY, Zhai H, Maibach HI. Percutaneous penetration enhancers:
An overview. Skin Pharmacol Physiol 2007;20:272-82.
Friend DS, Catz P, Heller J, Reid J, Baker R. Simple alkyl esters as skin permeation enhancers. J Control Release 1989; 9:33.
Bergstrom TK, Knutson K, De Noble LJ, Goates CY. Percutaneous
absorption enhancement of an ionic molecule by ethanol-water systems
in human skin. Pharm Res 1990;7:762-6.
Megrab NA, Williams AC, Barry BW. Oestradiol permeation across
human skin, silastic and snake skin membranes: The effects of ethanol/
water co-solvent systems. Int J Pharm 1995;116:101-12.
Williams AC. Transdermal and topical drug delivery: From theory to
clinical practise. London: Pharmaceutical Press; 2003.
Tan EL, Liu JC, Chien YW. Effect of cationic surfactants on the
transdermal permeation of ionized indomethacin. Drug Dev Ind Pharm
;19:685.
Ghosh TK, Habib MJ, Childs K, Alexander M. Transdermal delivery of
metoprolol comparison between hairless mouse and human cadaver
skin and effect of n-decylmethyl sulfoxide. Int J Pharm 1992;88:391-6.
Rosten M. The treatment of ichthyosis and hyperkeratotic conditions
with urea. Australas J Dermatol 1970;11:142-4.
Garala K, Faldu N, Basu B, Bhalodia R, Mehta K, Joshi B. Chemical
penetration enhancement. J Pharm Res 2009;2:1804-8.
Wong O, Tsuzuki N, Nghiem B, Kuehnhoff J, Itoh T, Masaki K, et al.
Unsaturated cyclic ureas as new non-toxic biodegradable transdermal
penetration enhancers: II. Evaluation study. Int J Pharm 1989;52:191-2.
Aqil M, Ahad A, Sultan Y, Ali A. Status of terpenes as skin penetration
enhancers. Drug Discov Today 2007;12:1061-7.
Vaddi HK. Terpenes in propylene glycol as skin-penetration enhancers:
Permeation and partition of haloperidol, fourier transform infrared
spectroscopy and differential scanning calorimetry. J Pharm Sci
;91:1639-51.
Weiner N, Williams N, Birch G. Topical delivery of liposomally
encapsulated interferon evaluated in cutaneous herpes guinea pig
model. Antimicrob Agents Chemother 1989;33:1217-21.
Madza F, Ozer AY, Ercan MT, Hincal AA. Preparation and characterisation
of urea niosomes: Invitro and in vivo studies. STP Pharm Sci 1997;7:
-14.
Cevc G. Transfersomes, liposomes and other lipid uspensions on the
skin: Permeation advancement, vesicle penetration and transdermal
drug delivery. Crit Rev Ther Drug Carrier Syst 1996;13:257-388.
Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to
the transdermal osmotic gradient and hydration force. Biochimica et
Biophysica Acta 1992;1104:226-32.
Touitou E, Godin B, Dayan N. Enhanced delivery of drugs into and
across the skin by ethosomal carriers. Drug Dev Res 2000;50:406-15.
Dean HJ, Fuller D, Osorio JE. Powder and particle-mediated approaches
for delivery of DNA and protein vaccines into the epidermis. Comp
Immunol Microbiol Infect Dis 2003;26:373-88.
Jacques SL, McAuliffe DJ, Blank IH, Parrish JA. Controlled removal of
human stratum corneum by pulsed laser. J Invest Dermatol 1987;88:
-93.
Nelson JS, McCullough JL, Glenn TC. Mid-infrared laser ablation of
stratum corneum enhances in vitro percutaneous transport of drugs. J
Invest Dermatol 1991;97:874-9.
Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated
microneedles: A novel approach to transdermal drug delivery. J Pharm
Sci 1998;87:922-5.
Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug
Deliv Rev 2004;56:581-7.
Kaushik S, Hord AH, Denson DD, McAllister DV, Smitra S, Allen MG, et
al. Lack of pain associated with microfabricated microneedles. Anesth
Analg 2001;92:502-4.
McAllister DV, Patel PN, Mayberry JL, Allen MG, Prausnitz MR. Solid
and hollow microneedles for transdermal drug delivery. Proceding in
International Sympossium-Controled Release of Bioactive Materials.
Boston: Deerfield, IL; 1999. p. 192-3.
Tachibana K, Tachibana S. Transdermal delivery of insulin by ultrasonic
vibration. J Pharm Pharmacol 1991;43:270-1.
Mitragotri S, Edwards D, Blankschtein D, Langer R. A mechanistic
study of ultrasonically enhanced transdermal drug delivery. J Pharm
Sci 1995;184:697-706.
Banga AK, Bose S, Ghosh TK. Iontophoresis and electroporation:
Comparisons and contrasts. Int J Pharm 1999;179:1-19.
Dixit N, Bali V, Baboota S, Ahuja A, Ali J. Iontophoresis: An approach
for controlled drug delivery: A review. Curr Drug Deliv 2007;4:1-10.
Phipps JB, Padmanabhan RV, Lattin GA. Iontophoresis delivery of model
inorganic and drug ion. J Pharm Sci 1989;78:365-9.
Yoshida NH, Roberts MS. Solute molecular size and transdermal
iontoporesis across excised human skin. J Control Release 1993;25:
-95.
Lopez RF, Bentley MV, Delgado-Charro MB, Guy RH. Iontophoretic
delivery of 5-aminolevulinic acid (ALA): Effect of pH. Pharm Res
;18:311-5.
Pillai O, Nair V, Panchagnula R. Transdermal iontophoresis of insulin:
IV. Influence of chemical enhancers. Int J Pharm 2004;269:109-20.
Cullander C, Guy RH. Sites of iontophoretic current flow into the skin:
Identification and characterization with the vibrating probe electrode.
J Invest Dermatol 1991;97:55-64.
Prausnitz MR, Gimm JA, Guy RH, Langer R, Weaver JC, Cullander C.
Imaging regions of transport across human stratum corneum during
high-voltage and low-voltage exposures. J Pharm Sci 1996;85:1363-70.
Medi BM, Hoselton S, Marepalli RB, Singh J. Skin targeted DNA vaccine
delivery using electroporation in rabbits: I: Efficacy. Int J Pharm
;294:53-63.
Wallace MS, Ridgeway B, Jun E, Schulteis G, Rabussay D, Zhang L.
Topical delivery of lidocaine in healthy volunteers by electroporation,
electroincorporation, or iontophoresis: an evaluation of skin
anesthesia. Reg Anesth Pain Med 2001;26:229-38.
Wu QH, Liang WQ, Bao JL, Ping QN. Enhanced transdermal delivery of
tetracaine by electroporesion. Int J Pharm 2000;202:121-4.
Conjeevaram R, Banga AK, Zhang L. Electrically modulated transdermal
delivery of fentanyl. Pharm Res 2002;19:440-4.
Meidan VM, Al-Khalili M, Michniak BB. Enhanced iontophoretic
delivery of buspirone hydrochloride across human skin using chemical
enhancers. Int J Pharm 2003;264:73-83.
Prausnitz MR. A practical assessment of transdermal drug delivery by
skin electroporation. Adv Drug Deliv Rev 1999;35:61-76.
Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman
E, et al. Human stratum corneum lipids: Characterization and regional
variations. J Lipid Res 1983;24:120-30.
Holleran WM, Takagi Y, Feingold KR, Menon GK, Legler G, Elias PM.
Processing of epidermal glucosylceremides is required for optimal
mammalian permeability barrier function. J Clin Invest 1993;91:1656-64.
Zuo Y, Zhuang DZ, Han R, Isaac G, Tobin JJ, McKee M, et al. ABCA12
maintains the epidermal lipid permeability barrier by facilitating
formation of ceramide linoleic esters. J Biol Chem 2008;283:36624-35.
Bouwstra J, Pilgram G, Gooris G, Koerten H, Ponec M. New aspects
of the skin barrier organization. Skin Pharmacol Appl Skin Physiol
;14:52-62.
Jui CT, Richard HG, Carl RT, Wen-Ni G, Kenneth RF, Peter ME. Metabolic
approaches to enhance transdermal drug delivery. 1. Effect of lipid
synthesis inhibitors. J Pharm Sci 1996;85:643-8.